The global artificial intelligence in healthcare market reached a value of US$ 3.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.7 Billion by 2027, exhibiting a CAGR of 31.23% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Artificial intelligence (AI) in healthcare is utilized for managing and analyzing data for performing clinical diagnosis and suggesting appropriate treatment plans for an ailment. It uses various software and sophisticated algorithms to evaluate symptoms and patterns of diseases while providing better guidance, feedback and support to the healthcare providers. Apart from this, systems equipped with AI can provide digital and virtual consultations to patients, offer drug creation and management facilities, and healthcare analysis through smart wearable devices.
Artificial Intelligence in Healthcare Market Trends:
The increasing utilization of robots for surgical and rehabilitation procedures in the healthcare industry is one of the key factors driving the growth of the market. Robots can efficiently conduct minimally invasive (MI) surgeries for neurologic, orthopedic and laparoscopic procedures. Furthermore, the emerging trend of digitalization in the healthcare sector is also providing a boost to the market. Various medical devices and systems are being equipped with AI for convenient and secure management of data. This further aids in generating patient-specific information which is utilized for providing personalized diagnostic and pharmaceutical services. The market is also being driven by the rising geriatric population and their increasing dependence on healthcare services. AI is largely being integrated into elderly care products, such as smart devices for assisted living, fall detection and virtual companions. These empathic robots can also provide care to physically and mentally challenged patients, while industrial robots are used to perform various routine tasks in healthcare centers. Other factors, including enhanced research and development (R&D), along with favorable healthcare policies by governments of several nations, are projected to drive the market in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial intelligence in healthcare market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on offering, technology, application and end-user.
Breakup by Offering:
Hardware
Software
Services
Breakup by Technology:
Machine Learning
Context-Aware Computing
Natural Language Processing
Others
Breakup by Application:
Robot-Assisted Surgery
Virtual Nursing Assistant
Administrative Workflow Assistance
Fraud Detection
Dosage Error Reduction
Clinical Trial Participant Identifier
Preliminary Diagnosis
Others
Breakup by End-User:
Healthcare Providers
Pharmaceutical and Biotechnology Companies
Patients
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Amazon Web Services Inc., Cloudmedx Inc., DeepMind, Enlitic Inc., General Vision Inc., Google Inc., International Business Machines, iCarbonX, Intel Corporation, Medtronic, Micron Technology Inc., Microsoft Corporation, Next It Corporation, Nuance Communications Inc., Nvidia Corporation, Siemens Healthcare, Welltok Inc., etc.
Key questions answered in this report:
How has the global artificial intelligence in healthcare market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global artificial intelligence in healthcare market?
What is the breakup of the market based on the offering?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global artificial intelligence in healthcare market and who are the key players?
What is the degree of competition in the industry?